Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYZK4776
Stock Name / FundiShares Healthcare Innovation UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerDRDR(GBX) LSE
ETF Ticker2B78(EUR) F
ETF Ticker2B78.DE(EUR) CXE
ETF TickerDRDR.LS(GBX) CXE
ETF TickerHEAL.AS(EUR) CXE
ETF TickerHEAL.LS(USD) CXE
ETF TickerHEALz(USD) CXE
ETF TickerHEAL(EUR) ETF Plus
ETF TickerDRDR.L(GBP) LSE

Holdings detail for BEAM

Stock NameBeam Therapeutics Inc
TickerBEAM(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS07373V1052

Show aggregate BEAM holdings

News associated with BEAM

Beam Therapeutics (NASDAQ:BEAM) Earns “Buy” Rating from HC Wainwright
Beam Therapeutics (NASDAQ:BEAM – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a research note issued on Monday,Benzinga reports. They currently have a $80.00 price target on the stock. HC Wainwright’s target price points to a potential upside of 249.19% from the company’s previous close. A number […] - 2025-09-17 02:46:44
Beam Therapeutics (NASDAQ:BEAM) Downgraded by Wall Street Zen to “Sell”
Wall Street Zen lowered shares of Beam Therapeutics (NASDAQ:BEAM – Free Report) from a hold rating to a sell rating in a report published on Sunday. BEAM has been the topic of several other reports. Barclays lowered their price objective on shares of Beam Therapeutics from $25.00 to $21.00 and set an “equal weight” rating […] - 2025-09-15 04:42:44
Beam Therapeutics (NASDAQ:BEAM) Stock Rating Upgraded by Wall Street Zen
Beam Therapeutics (NASDAQ:BEAM – Get Free Report) was upgraded by research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued on Saturday. Several other equities analysts have also commented on BEAM. Cantor Fitzgerald raised Beam Therapeutics to a “strong-buy” rating in a report on Monday, July […] - 2025-09-08 03:02:55
Beam Therapeutics Inc. (NASDAQ:BEAM) Receives Consensus Recommendation of “Buy” from Brokerages
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) has been assigned a consensus rating of “Buy” from the fourteen research firms that are covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a hold rating, nine have issued a buy rating and three have assigned a strong buy rating to the […] - 2025-08-07 02:38:51
Victory Capital Management Inc. Has $207,000 Stock Position in Beam Therapeutics Inc. (NASDAQ:BEAM)
Victory Capital Management Inc. boosted its position in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 18.0% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 10,612 shares of the company’s stock after purchasing an additional 1,618 shares during the period. Victory Capital […] - 2025-08-04 05:14:52
Bank of New York Mellon Corp Boosts Stock Position in Beam Therapeutics Inc. (NASDAQ:BEAM)
Bank of New York Mellon Corp increased its stake in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 14.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 318,026 shares of the company’s stock after buying an additional […] - 2025-07-24 04:27:08
Arizona State Retirement System Boosts Position in Beam Therapeutics Inc. (NASDAQ:BEAM)
Arizona State Retirement System raised its position in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 25.6% in the 1st quarter, Holdings Channel reports. The fund owned 25,534 shares of the company’s stock after purchasing an additional 5,197 shares during the period. Arizona State Retirement System’s holdings in Beam Therapeutics were worth $499,000 as of […] - 2025-07-22 07:42:58
Arizona State Retirement System Has $499,000 Stock Position in Beam Therapeutics Inc. (NASDAQ:BEAM)
Arizona State Retirement System boosted its position in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 25.6% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 25,534 shares of the company’s stock after purchasing an additional 5,197 shares during the period. Arizona State Retirement System’s holdings in Beam […] - 2025-07-22 06:57:02
D.A. Davidson & CO. Has $1.38 Million Position in Beam Therapeutics Inc. (NASDAQ:BEAM)
D.A. Davidson & CO. boosted its position in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 37.8% in the 1st quarter, HoldingsChannel reports. The firm owned 70,857 shares of the company’s stock after acquiring an additional 19,448 shares during the period. D.A. Davidson & CO.’s holdings in Beam Therapeutics were worth $1,384,000 as of its […] - 2025-07-09 05:53:15
QRG Capital Management Inc. Sells 870 Shares of Beam Therapeutics Inc. (NASDAQ:BEAM)
QRG Capital Management Inc. cut its stake in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 5.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 16,635 shares of the company’s stock after selling 870 shares during the period. QRG […] - 2025-06-24 04:46:59
Beam Therapeutics Inc. (NASDAQ:BEAM) Given Average Recommendation of “Buy” by Analysts
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) has been assigned an average recommendation of “Buy” from the fifteen analysts that are covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and two have assigned a strong buy rating to the […] - 2025-06-23 04:48:53
Implied ESGV Analyst Target Price: $116
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-26 08:27:28
Beam Therapeutics Inc. (NASDAQ:BEAM) Shares Purchased by Northern Trust Corp
Northern Trust Corp boosted its position in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 7.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 740,506 shares of the company’s stock after acquiring an additional 49,415 shares during the period. Northern Trust […] - 2025-05-14 05:54:50
Stifel Financial Corp Acquires 2,976 Shares of Beam Therapeutics Inc. (NASDAQ:BEAM)
Stifel Financial Corp boosted its holdings in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 27.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,662 shares of the company’s stock after acquiring an additional 2,976 shares during the quarter. Stifel Financial Corp’s […] - 2025-05-14 04:56:47
Beam Therapeutics (NASDAQ:BEAM) Trading Down 6.8% Following Weak Earnings
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) shares traded down 6.8% during mid-day trading on Tuesday following a dissappointing earnings announcement. The company traded as low as $18.37 and last traded at $18.47. 326,775 shares traded hands during mid-day trading, a decline of 83% from the average session volume of 1,947,803 shares. The stock […] - 2025-05-08 02:42:51
Dimensional Fund Advisors LP Has $38.16 Million Stock Position in Beam Therapeutics Inc. (NASDAQ:BEAM)
Dimensional Fund Advisors LP boosted its stake in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 24.0% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,538,398 shares of the company’s stock after purchasing an additional 298,067 shares during the period. Dimensional Fund Advisors […] - 2025-05-05 05:20:53
Implied VBK Analyst Target Price: $326
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-04-24 08:03:06
Beam Therapeutics Inc. (NASDAQ:BEAM) Stake Lifted by Sterling Capital Management LLC
Sterling Capital Management LLC raised its stake in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 816.0% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 2,409 shares of the company’s stock after buying an additional 2,146 shares during the quarter. Sterling Capital Management LLC’s holdings in Beam […] - 2025-04-24 06:31:07
Beam Therapeutics Target of Unusually Large Options Trading (NASDAQ:BEAM)
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) was the recipient of some unusual options trading activity on Tuesday. Investors acquired 10,060 put options on the company. This is an increase of approximately 1,089% compared to the typical daily volume of 846 put options. Beam Therapeutics Stock Up 3.9 % Beam Therapeutics stock opened at […] - 2025-04-24 02:30:49
Beam Therapeutics Inc. (NASDAQ:BEAM) Shares Purchased by LPL Financial LLC
LPL Financial LLC grew its holdings in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 5.6% during the fourth quarter, Holdings Channel reports. The firm owned 27,698 shares of the company’s stock after acquiring an additional 1,462 shares during the quarter. LPL Financial LLC’s holdings in Beam Therapeutics were worth $687,000 as of […] - 2025-04-23 04:22:56
Federated Hermes Inc. Decreases Position in Beam Therapeutics Inc. (NASDAQ:BEAM)
Federated Hermes Inc. decreased its holdings in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 20.8% in the 4th quarter, HoldingsChannel.com reports. The fund owned 29,709 shares of the company’s stock after selling 7,792 shares during the quarter. Federated Hermes Inc.’s holdings in Beam Therapeutics were worth $737,000 as of its most recent SEC filing. […] - 2025-04-17 05:16:55
Beam Therapeutics Inc. (NASDAQ:BEAM) Holdings Decreased by Russell Investments Group Ltd.
Russell Investments Group Ltd. cut its position in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 6.2% during the 4th quarter, HoldingsChannel.com reports. The firm owned 176,181 shares of the company’s stock after selling 11,664 shares during the period. Russell Investments Group Ltd.’s holdings in Beam Therapeutics were worth $4,369,000 as of its […] - 2025-04-16 05:06:53
Geode Capital Management LLC Trims Stock Holdings in Beam Therapeutics Inc. (NASDAQ:BEAM)
Geode Capital Management LLC cut its holdings in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 0.2% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,804,374 shares of the company’s stock after selling 3,309 shares during the quarter. Geode Capital Management […] - 2025-04-15 05:01:01
JPMorgan Chase & Co. Sells 125,567 Shares of Beam Therapeutics Inc. (NASDAQ:BEAM)
JPMorgan Chase & Co. lowered its holdings in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 19.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 513,671 shares of the company’s stock after selling 125,567 shares during the period. […] - 2025-04-14 04:36:51
Alliancebernstein L.P. Has $5.28 Million Holdings in Beam Therapeutics Inc. (NASDAQ:BEAM)
Alliancebernstein L.P. lifted its stake in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 149.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 212,804 shares of the company’s stock after purchasing an additional 127,494 shares during the quarter. Alliancebernstein L.P.’s holdings in […] - 2025-04-13 05:44:47
KLP Kapitalforvaltning AS Makes New Investment in Beam Therapeutics Inc. (NASDAQ:BEAM)
KLP Kapitalforvaltning AS purchased a new stake in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 13,400 shares of the company’s stock, valued at approximately $332,000. Other hedge funds and other institutional investors have […] - 2025-04-06 07:35:04
Mitsubishi UFJ Asset Management Co. Ltd. Has $244,000 Stake in Beam Therapeutics Inc. (NASDAQ:BEAM)
Mitsubishi UFJ Asset Management Co. Ltd. lowered its position in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 9.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 9,613 shares of the company’s stock after selling 995 shares during the period. Mitsubishi UFJ Asset Management Co. […] - 2025-04-04 05:12:58
Stocks Tumble on Weaker US Consumer Spending and Sticky Price Pressures
The S&P 500 Index ($SPX ) (SPY ) today is down -1.47%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.89%. June E-mini S&P futures (ESM25 ) are down -1.43%, and June E-mini Nasdaq futures... - 2025-03-28 18:31:32
AlphaQuest LLC Reduces Holdings in Beam Therapeutics Inc. (NASDAQ:BEAM)
AlphaQuest LLC trimmed its stake in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 92.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,610 shares of the company’s stock after selling 33,583 shares during the period. AlphaQuest LLC’s holdings in Beam Therapeutics […] - 2025-03-20 06:13:05
Beam Therapeutics (NASDAQ:BEAM) Earns Overweight Rating from Cantor Fitzgerald
Beam Therapeutics (NASDAQ:BEAM – Get Free Report)‘s stock had its “overweight” rating reaffirmed by research analysts at Cantor Fitzgerald in a research report issued on Wednesday,Benzinga reports. BEAM has been the subject of several other research reports. Guggenheim reaffirmed a “buy” rating and issued a $78.00 price objective on shares of Beam Therapeutics in a […] - 2025-03-14 04:44:57

iShares Healthcare Innovation UCITS ETF USD (Acc) BEAM holdings

DateNumber of BEAM Shares HeldBase Market Value of BEAM SharesLocal Market Value of BEAM SharesChange in BEAM Shares HeldChange in BEAM Base ValueCurrent Price per BEAM Share HeldPrevious Price per BEAM Share Held
2025-11-11 (Tuesday)121,886USD 2,739,997BEAM holding increased by 101165USD 2,739,9970USD 101,165 USD 22.48 USD 21.65
2025-11-10 (Monday)121,886USD 2,638,832BEAM holding decreased by -68256USD 2,638,8320USD -68,256 USD 21.65 USD 22.21
2025-11-07 (Friday)121,886USD 2,707,088BEAM holding decreased by -114573USD 2,707,0880USD -114,573 USD 22.21 USD 23.15
2025-11-06 (Thursday)121,886USD 2,821,661BEAM holding increased by 9751USD 2,821,6610USD 9,751 USD 23.15 USD 23.07
2025-11-05 (Wednesday)121,886USD 2,811,910BEAM holding increased by 40222USD 2,811,9100USD 40,222 USD 23.07 USD 22.74
2025-11-04 (Tuesday)121,886USD 2,771,688BEAM holding decreased by -184048USD 2,771,6880USD -184,048 USD 22.74 USD 24.25
2025-11-03 (Monday)121,886USD 2,955,736BEAM holding decreased by -92633USD 2,955,7360USD -92,633 USD 24.25 USD 25.01
2025-10-31 (Friday)121,886USD 3,048,369BEAM holding increased by 147482USD 3,048,3690USD 147,482 USD 25.01 USD 23.8
2025-10-30 (Thursday)121,886USD 2,900,887BEAM holding decreased by -118229USD 2,900,8870USD -118,229 USD 23.8 USD 24.77
2025-10-29 (Wednesday)121,886USD 3,019,116BEAM holding decreased by -202331USD 3,019,1160USD -202,331 USD 24.77 USD 26.43
2025-10-28 (Tuesday)121,886USD 3,221,447BEAM holding decreased by -36566USD 3,221,4470USD -36,566 USD 26.43 USD 26.73
2025-10-27 (Monday)121,886USD 3,258,013BEAM holding decreased by -149920USD 3,258,0130USD -149,920 USD 26.73 USD 27.96
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of BEAM by Blackrock for IE00BYZK4776

Show aggregate share trades of BEAM

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-10-24SELL-1,03627.96028.710 28.635USD -29,666 22.47 Loss of -6,388 on sale
2025-09-11BUY52021.55021.590 21.586USD 11,225 22.11
2025-07-08SELL-51820.30020.710 20.669USD -10,707 22.31 Profit of 848 on sale
2025-06-24SELL-52117.15017.380 17.357USD -9,043 22.57 Profit of 2,715 on sale
2025-06-23SELL-52116.71016.930 16.908USD -8,809 22.61 Profit of 2,970 on sale
2025-06-20BUY38,29416.76017.303 17.249USD 660,522 22.65
2025-06-11SELL-36217.89018.450 18.394USD -6,659 22.95 Profit of 1,648 on sale
2025-05-30SELL-36315.83016.385 16.330USD -5,928 23.31 Profit of 2,536 on sale
2025-05-21BUY36217.22017.780 17.724USD 6,416 23.70
2025-05-14SELL-2,16617.24018.420 18.302USD -39,642 23.92 Profit of 12,165 on sale
2025-04-30SELL-36119.93020.080 20.065USD -7,243 24.46 Profit of 1,588 on sale
2025-04-28SELL-36119.80020.173 20.136USD -7,269 24.56 Profit of 1,596 on sale
2025-04-25SELL-36119.52019.974 19.929USD -7,194 24.61 Profit of 1,689 on sale
2025-04-11SELL-2,19615.47015.665 15.645USD -34,358 25.20 Profit of 20,977 on sale
2025-04-08SELL-1,09214.54016.190 16.025USD -17,499 25.54 Profit of 10,386 on sale
2025-04-07SELL-79215.30016.040 15.966USD -12,645 25.65 Profit of 7,671 on sale
2025-03-31SELL-72619.53021.380 21.195USD -15,388 26.03 Profit of 3,510 on sale
2025-03-21SELL-72223.30023.430 23.417USD -16,907 26.28 Profit of 2,065 on sale
2025-03-12SELL-36427.42028.490 28.383USD -10,331 26.47 Loss of -697 on sale
2025-02-28SELL-36426.34027.290 27.195USD -9,899 26.47 Loss of -265 on sale
2025-02-25BUY36429.84032.710 32.423USD 11,802 26.38
2025-02-20SELL-36333.14034.710 34.553USD -12,543 26.11 Loss of -3,065 on sale
2025-02-19BUY72634.09034.820 34.747USD 25,226 25.97
2025-02-18BUY36333.49035.250 35.074USD 12,732 25.83
2024-12-30BUY2,33125.27026.410 26.296USD 61,296 25.10
2024-12-06SELL-34826.71028.000 27.871USD -9,699 24.82 Loss of -1,063 on sale
2024-12-04SELL-34826.02027.120 27.010USD -9,399 24.76 Loss of -783 on sale
2024-12-03SELL-69825.98027.950 27.753USD -19,372 24.72 Loss of -2,119 on sale
2024-11-21SELL-35223.58024.710 24.597USD -8,658 23.85 Loss of -263 on sale
2024-11-20SELL-35924.49025.870 25.732USD -9,238 23.81 Loss of -689 on sale
2024-11-19SELL-35925.29025.390 25.380USD -9,111 23.73 Loss of -594 on sale
2024-11-18SELL-1,40024.12025.050 24.957USD -34,940 23.70 Loss of -1,758 on sale
2024-11-12SELL-35027.94030.655 30.384USD -10,634 23.42 Loss of -2,438 on sale
2024-11-07SELL-35026.10027.165 27.059USD -9,470 22.93 Loss of -1,444 on sale
2024-11-05SELL-70023.93024.790 24.704USD -17,293 22.51 Loss of -1,538 on sale
2024-10-28SELL-35022.35022.740 22.701USD -7,945 22.27 Loss of -151 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of BEAM

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19902,6942,1901,217,28174.2%
2025-09-181,122,5532,1891,640,60768.4%
2025-09-171,023,7333,8001,519,53867.4%
2025-09-16874,3396,1271,309,36766.8%
2025-09-15538,772247846,75063.6%
2025-09-12707,8961,4611,138,94962.2%
2025-09-11875,8556,8201,546,79656.6%
2025-09-10584,7521,614920,94163.5%
2025-09-09518,7102,293845,13961.4%
2025-09-08801,5075311,193,47367.2%
2025-09-051,238,7021,6372,031,03661.0%
2025-09-04900,7268001,465,11161.5%
2025-09-032,412,9004,9744,102,04458.8%
2025-09-02378,279147620,57161.0%
2025-08-29467,30111760,35261.5%
2025-08-28548,9910842,79965.1%
2025-08-27408,469600672,07960.8%
2025-08-26492,3140682,16272.2%
2025-08-25519,376200776,15266.9%
2025-08-22441,803100965,14445.8%
2025-08-21627,68501,043,50960.2%
2025-08-20809,0612641,230,70965.7%
2025-08-19782,9021,1001,398,03356.0%
2025-08-18556,5491,3941,234,38545.1%
2025-08-15461,18460779,89759.1%
2025-08-14848,848361,578,76053.8%
2025-08-13638,94001,311,07048.7%
2025-08-12670,9271,4551,113,55160.3%
2025-08-11466,6511,300802,25658.2%
2025-08-08323,809557746,12343.4%
2025-08-07372,64679763,80548.8%
2025-08-06669,329411,014,66366.0%
2025-08-051,074,6661,3471,597,18267.3%
2025-08-04529,057294703,68175.2%
2025-08-01702,8841,6191,140,50361.6%
2025-07-31484,476234942,89051.4%
2025-07-30702,8972,3681,181,92459.5%
2025-07-29557,7493,448868,26564.2%
2025-07-28508,5282,673759,68366.9%
2025-07-25416,9911,572695,00660.0%
2025-07-24538,292931,234,25143.6%
2025-07-23503,90010,0951,044,03548.3%
2025-07-22419,910309811,77851.7%
2025-07-21666,9243,4081,264,47252.7%
2025-07-18379,990371881,11543.1%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.